Recombinant Immunotoxins With Albumin-Binding Domains Have Long Half-Lives and High Antitumor Activity

Proceedings of the National Academy of Sciences of the United States of America- United States

doi 10.1073/pnas.1721780115

Full Text

Abstract

Available in

Categories

Multidisciplinary

Date

March 26, 2018

Authors

Publisher

Proceedings of the National Academy of Sciences

Related search

Recombinant Anti-erbB2 Immunotoxins Containing Pseudomonas Exotoxin.

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

Breton

Inhibition of Serotonin Synthesis May Have Antitumor Activity? Long‐Term Efficacy in a Patient With Gastrointestinal Neuroendocrine Tumor

Cancer Research

English

Fusion of Lysostaphin to an Albumin Binding Domain Prolongs Its Half-Life and Bactericidal Activity in the Systemic Circulation

Organic Chemistry

Molecular Medicine

Analytical Chemistry

Theoretical Chemistry

Pharmaceutical Science

English

Half-Lives of La132 and La135

Physical Review C

High Energy Physics

English

Functional Studies on Recombinant Domains of Mac-2-Binding Protein

Journal of Biological Chemistry

Molecular Biology

English

Molecular Immunolabeling With Recombinant Single-Chain Variable Fragment (scFv) Antibodies Designed With Metal-Binding Domains

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English

Conformational Transitions of the Three Recombinant Domains of Human Serum Albumin Depending on pH

Journal of Biological Chemistry

Molecular Biology

English

A Tetraethylene Glycol Coat Gives Gold Nanoparticles Long in Vivo Half-Lives With Minimal Increase in Size

International Journal of Nanomedicine

Organic Chemistry

Pharmaceutical Science

English

Binding Activity of Streptococcus Canis for Albumin and Other Plasma Proteins

English